ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
|
|
Speckled
|
81 |
28K |
3 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
81
|
28K
|
3
|
|
ASX - By Stock
|
BOQ |
Re:
Ann: Dividend/Distribution - BOQ
|
|
Speckled
|
3 |
3.0K |
3 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
3
|
3.0K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
|
|
Speckled
|
81 |
28K |
0 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
81
|
28K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
Speckled
|
458 |
152K |
5 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
458
|
152K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
|
|
Speckled
|
81 |
28K |
4 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
81
|
28K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
|
|
Speckled
|
81 |
28K |
2 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
81
|
28K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
|
|
Speckled
|
81 |
28K |
0 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
81
|
28K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
|
|
Speckled
|
81 |
28K |
15 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
81
|
28K
|
15
|
|
ASX - By Stock
|
OCC |
Re:
Ann: First orders for Striate and Remplir
|
|
Speckled
|
37 |
12K |
2 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
37
|
12K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: First orders for Striate and Remplir
|
|
Speckled
|
37 |
12K |
2 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
37
|
12K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: First orders for Striate and Remplir
|
|
Speckled
|
37 |
12K |
9 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
37
|
12K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: First orders for Striate and Remplir
|
|
Speckled
|
37 |
12K |
14 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
37
|
12K
|
14
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate Global License and Distribution Agreement Update
|
|
Speckled
|
69 |
22K |
1 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
69
|
22K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Speckled
|
42 |
15K |
2 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
42
|
15K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate Global License and Distribution Agreement Update
|
|
Speckled
|
69 |
22K |
6 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
69
|
22K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate Global License and Distribution Agreement Update
|
|
Speckled
|
69 |
22K |
13 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
69
|
22K
|
13
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
1.6K
|
492K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Speckled
|
18 |
7.2K |
9 |
31/07/22 |
31/07/22 |
ASX - By Stock
|
18
|
7.2K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate Global License and Distribution Agreement Update
|
|
Speckled
|
69 |
22K |
7 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
69
|
22K
|
7
|
|
ASX - By Stock
|
ANZ |
Re:
Ann: ANZ withdraws from MYOB discussions
|
|
Speckled
|
6 |
3.1K |
2 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
6
|
3.1K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
pennies starting to drop ..??
|
|
Speckled
|
1 |
574 |
6 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
1
|
574
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Tendon Clinical Study Success
|
|
Speckled
|
241 |
63K |
2 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
241
|
63K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Tendon Clinical Study Success
|
|
Speckled
|
241 |
63K |
8 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
241
|
63K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Tendon Clinical Study Success
|
|
Speckled
|
241 |
63K |
4 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
241
|
63K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
6 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
1.6K
|
492K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
4 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
1.6K
|
492K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
Speckled
|
458 |
152K |
2 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
458
|
152K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Speckled
|
298 |
81K |
10 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
298
|
81K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Speckled
|
298 |
81K |
6 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
298
|
81K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Speckled
|
298 |
81K |
11 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
298
|
81K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Speckled
|
298 |
81K |
7 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
298
|
81K
|
7
|
|
ASX - By Stock
|
BCI |
Re:
BCI's Mardie - The Road to 6.0Mtpa Salt and 160ktpa SOP
|
|
Speckled
|
26 |
11K |
1 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
26
|
11K
|
1
|
|
ASX - By Stock
|
BCI |
Re:
BCI's Mardie - The Road to 6.0Mtpa Salt and 160ktpa SOP
|
|
Speckled
|
26 |
11K |
3 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
26
|
11K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
5 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
1.6K
|
492K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
3 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
1.6K
|
492K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
10 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
1.6K
|
492K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
7 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
1.6K
|
492K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
5 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
1.6K
|
492K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Final Data Readout for Orthocells Nerve Reconstruction Study
|
|
Speckled
|
59 |
19K |
2 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
59
|
19K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Final Data Readout for Orthocells Nerve Reconstruction Study
|
|
Speckled
|
59 |
19K |
3 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
59
|
19K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
5 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
1.6K
|
492K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
5 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
1.6K
|
492K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
3 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
1.6K
|
492K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
3 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
1.6K
|
492K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
10 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
1.6K
|
492K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
3 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
1.6K
|
492K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
9 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
1.6K
|
492K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Speckled
|
25 |
10K |
3 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
25
|
10K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Speckled
|
25 |
10K |
9 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
25
|
10K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Speckled
|
25 |
10K |
4 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
25
|
10K
|
4
|
|